180 related articles for article (PubMed ID: 33149470)
1. An Immunohistochemical Study Showing Ki-67 as an Analytical Marker in Oral Malignant and Premalignant Lesions.
Dash KC; Mahapatra N; Bhuyan L; Panda A; Behura SS; Mishra P
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S274-S278. PubMed ID: 33149470
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 Expression as a Prognostic Marker: A Comparative Immunohistochemical Analysis of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Gupta V; Ramalingam K; Yasothkumar D; Debnath D; Sundar V
Cureus; 2023 May; 15(5):e38941. PubMed ID: 37313057
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ki-67 in normal oral epithelium, leukoplakic oral epithelium and oral squamous cell carcinoma.
Birajdar SS; Radhika M; Paremala K; Sudhakara M; Soumya M; Gadivan M
J Oral Maxillofac Pathol; 2014 May; 18(2):169-76. PubMed ID: 25328294
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
6. An Immunohistochemical Study of HIF-1 Alpha in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Patel NR; Jain L; Mahajan AM; Hiray PV; Shinde SS; Patel PA
Indian J Otolaryngol Head Neck Surg; 2019 Dec; 71(4):435-441. PubMed ID: 31750100
[TBL] [Abstract][Full Text] [Related]
7. Suprabasal expression of Ki-67 as a marker for the severity of oral epithelial dysplasia and oral squamous cell carcinoma.
Dwivedi N; Chandra S; Kashyap B; Raj V; Agarwal A
Contemp Clin Dent; 2013 Jan; 4(1):7-12. PubMed ID: 23853445
[TBL] [Abstract][Full Text] [Related]
8. MUC4 Expression in Oral Dysplastic Epithelium and Oral Squamous Cell Carcinoma: An Immunohistochemical Study.
Abidullah M; Nahar P; Ahmed SA; Kothari H; Vakeel S
J Int Soc Prev Community Dent; 2023; 13(2):124-132. PubMed ID: 37223448
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
Kalaimani G; Rao UDK; Joshua E; Ranganathan K
Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
[TBL] [Abstract][Full Text] [Related]
10. The Expression of Methyltransferase-Like 3 in Oral Precancerous Lesions and Oral Squamous Cell Carcinoma.
Udompatanakorn C; Taebunpakul P
Eur J Dent; 2023 May; 17(2):349-356. PubMed ID: 35785826
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of glucose transporter-1 expression in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical study.
Patlolla P; N Shyam NDV; Kumar GK; Narayen V; Konda P; Mudududla P
J Oral Maxillofac Pathol; 2020; 24(3):578. PubMed ID: 33967505
[TBL] [Abstract][Full Text] [Related]
12. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
Torres-Rendon A; Roy S; Craig GT; Speight PM
Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805
[TBL] [Abstract][Full Text] [Related]
13. A Comparative Immunohistochemical Study of Presence and Distribution Pattern of Stromal Myofibroblast in Oral Dysplasia and in Different Grades of Oral Squamous Cell Carcinoma.
Bhattacharjee K; Girish HC; Murgod S; Alshame AMJ; Shyamala K; Nayak VN
J Int Soc Prev Community Dent; 2018; 8(5):451-456. PubMed ID: 30430074
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study.
Kotrashetti VS; Nayak R; Bhat K; Hosmani J; Somannavar P
Biotech Histochem; 2013 Aug; 88(6):311-22. PubMed ID: 23651260
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study.
Humayun S; Prasad VR
Natl J Maxillofac Surg; 2011 Jan; 2(1):38-46. PubMed ID: 22442608
[TBL] [Abstract][Full Text] [Related]
16. Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders.
Sharada P; Swaminathan U; Nagamalini BR; Kumar KV; Ashwini BK; Lavanya V
J Oral Maxillofac Pathol; 2018; 22(1):40-47. PubMed ID: 29731555
[TBL] [Abstract][Full Text] [Related]
17. Expression of PD-L1 and p-RPS6 in epithelial dysplasia and squamous cell carcinoma of the oral cavity.
Hanroongsri J; Amornphimoltham P; Younis RH; Chaisuparat R
Front Oral Health; 2024; 5():1337582. PubMed ID: 38370876
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of programmed cell death 4 protein in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma.
Desai KM; Kale AD
J Oral Maxillofac Pathol; 2017; 21(3):462. PubMed ID: 29391736
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma.
Arora M; Mane DR
J Oral Maxillofac Pathol; 2018; 22(2):279-280. PubMed ID: 30158786
[TBL] [Abstract][Full Text] [Related]
20. Expression of Bcl-2 and MIB-1 Markers in Oral Squamous Cell Carcinoma (OSCC)- A Comparative Study.
Garewal J; Garewal R; Sircar K
J Clin Diagn Res; 2014 Jul; 8(7):QC01-4. PubMed ID: 25177617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
